Cargando…
SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
Initial reports of SARS-CoV-2 caused COVID-19 suggested that patients with malignant diseases were at increased risk for infection and its severe consequences. In order to provide early United States population-based assessments of SARS-CoV-2 primary infections in unvaccinated patients with hematolo...
Autores principales: | Wang, Lindsey, Wang, William, Xu, Rong, Berger, Nathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526006/ https://www.ncbi.nlm.nih.gov/pubmed/36494154 http://dx.doi.org/10.1016/j.beha.2022.101384 |
Ejemplares similares
-
Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma
por: Wang, Lindsey, et al.
Publicado: (2021) -
Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021
por: Wang, William, et al.
Publicado: (2022) -
Primary and Recall Immune Responses to SARS-CoV-2 in Breakthrough Infection
por: D’Orso, Silvia, et al.
Publicado: (2023) -
Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022) -
Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections
por: Arsuffi, Stefania, et al.
Publicado: (2023)